Array
(
[id] => 566
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/566.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:02
[updatetime] => 2024-01-11 15:13:02
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => Routine pre-operative ICA is not recommended in stable CCS patients undergoing low- or intermediate-risk NCS. （Evidence: Level C，Recommendation:Class III）
[laiyuan] => 对于接受低或中风险非心脏手术的稳定慢性冠状动脉综合征患者，不建议常规术前行有创冠状动脉造影术。（证据级别：Level C ；推荐强度：Class III）
[znzldj] => A
[_inputtime] => 1704957182
[_updatetime] => 1704957182
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于接受低或中风险非心脏手术的稳定慢性冠状动脉综合征患者，不建议常规术前行有创冠状动脉造影术。（证据级别：Level C ；推荐强度：Class III）
Routine pre-operative ICA is not recommended in stable CCS patients undergoing low- or intermediate-risk NCS. （Evidence: Level C，Recommendation:Class III）
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 567
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/567.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:02
[updatetime] => 2024-01-11 15:13:02
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => It is recommended to assess cardiorespiratory fitness to estimate peri-operative CV risk in obese patients, with particular attention to those undergoing intermediate- and high-risk NCS.(Evidence: Level B ，Recommendation: Class Ⅰ)
[laiyuan] => 推荐评估心肺功能，以估计肥胖患者的围手术期心血管风险，尤其注意接受中危和高危NCS的患者。（证据级别：Level B ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957182
[_updatetime] => 1704957182
[_nrjc] =>
[_nrsh] =>
)
推荐意见
推荐评估心肺功能，以估计肥胖患者的围手术期心血管风险，尤其注意接受中危和高危NCS的患者。（证据级别：Level B ；推荐强度：Class Ⅰ）
It is recommended to assess cardiorespiratory fitness to estimate peri-operative CV risk in obese patients, with particular attention to those undergoing intermediate- and high-risk NCS.(Evidence: Level B ，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 568
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/568.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:02
[updatetime] => 2024-01-11 15:13:02
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => Routine referral for cardiac work-up, coronary angiography, or CPET prior to elective surgery for PAD or AAA is not recommended.（Evidence：Level C,Recommendation：Class Ⅲ）
[laiyuan] => 不推荐在外周动脉疾病或腹主动脉瘤择期手术前常规转诊进行心脏检查、冠状动脉造影或心肺运动试验。（证据级别：Level C ；推荐强度：Class Ⅲ）
[znzldj] => A
[_inputtime] => 1704957182
[_updatetime] => 1704957182
[_nrjc] =>
[_nrsh] =>
)
推荐意见
不推荐在外周动脉疾病或腹主动脉瘤择期手术前常规转诊进行心脏检查、冠状动脉造影或心肺运动试验。（证据级别：Level C ；推荐强度：Class Ⅲ）
Routine referral for cardiac work-up, coronary angiography, or CPET prior to elective surgery for PAD or AAA is not recommended.（Evidence：Level C,Recommendation：Class Ⅲ）
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 569
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/569.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:02
[updatetime] => 2024-01-11 15:13:02
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with diabetes or disturbed glucose metabolism, a pre-operative HbA1c is recommended, if this measurement has been not performed in the previous 3 months. In case of HbA1c ≥8.5% (≥69 mmol/mol), elective NCS should be postponed, if safe and practical.（Evidence：Level B ,Recommendation：Class 1）
[laiyuan] => 对于糖尿病或糖代谢紊乱的患者，如果前3个月内未进行术前HbA1c测量，推荐术前测量。如果HbA1c≥8.5%(≥69 mmol/mol)，若安全可行，应推迟接受NCS。（证据级别：Level B ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957182
[_updatetime] => 1704957182
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于糖尿病或糖代谢紊乱的患者，如果前3个月内未进行术前HbA1c测量，推荐术前测量。如果HbA1c≥8.5%(≥69 mmol/mol)，若安全可行，应推迟接受NCS。（证据级别：Level B ；推荐强度：Class Ⅰ）
In patients with diabetes or disturbed glucose metabolism, a pre-operative HbA1c is recommended, if this measurement has been not performed in the previous 3 months. In case of HbA1c ≥8.5% (≥69 mmol/mol), elective NCS should be postponed, if safe and practical.（Evidence：Level B ,Recommendation：Class 1）
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 514
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/514.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => After elective PCI, it is recommended to delay time-sensitive NCS until a minimum of 1 month of DAPT treatment has been given. (Evidence: Level B，Recommendation: Class Ⅰ)
[laiyuan] => 择期经皮冠状动脉介入治疗术后，推荐延迟时间敏感的非心脏手术，直至给予至少1个月的双联抗血小板治疗。（证据级别：Level B ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
择期经皮冠状动脉介入治疗术后，推荐延迟时间敏感的非心脏手术，直至给予至少1个月的双联抗血小板治疗。（证据级别：Level B ；推荐强度：Class Ⅰ）
After elective PCI, it is recommended to delay time-sensitive NCS until a minimum of 1 month of DAPT treatment has been given. (Evidence: Level B，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 515
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/515.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => It is recommended to delay elective NCS until 6 months after elective PCI and 12 months after an ACS. (Evidence: Level A，Recommendation: Class Ⅰ)
[laiyuan] => 推荐将择期NCS延迟至择期经皮冠状动脉介入治疗后6个月和急性冠脉综合征后12个月。（证据级别：Level A ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
推荐将择期NCS延迟至择期经皮冠状动脉介入治疗后6个月和急性冠脉综合征后12个月。（证据级别：Level A ；推荐强度：Class Ⅰ）
It is recommended to delay elective NCS until 6 months after elective PCI and 12 months after an ACS. (Evidence: Level A，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 516
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/516.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => Routine pre-operative ICA is not recommended in stable CCS patients undergoing low- and intermediate-risk NCS. (Evidence: Level C，Recommendation: Class Ⅲ)
[laiyuan] => 对于接受低风险和中等风险NCS的稳定慢性冠状动脉综合征患者，不推荐进行常规术前侵入性冠状动脉造影。（证据级别：Level C ；推荐强度：Class Ⅲ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于接受低风险和中等风险NCS的稳定慢性冠状动脉综合征患者，不推荐进行常规术前侵入性冠状动脉造影。（证据级别：Level C ；推荐强度：Class Ⅲ）
Routine pre-operative ICA is not recommended in stable CCS patients undergoing low- and intermediate-risk NCS. (Evidence: Level C，Recommendation: Class Ⅲ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 517
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/517.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => A pre-operative assessment for concomitant cardiac conditions is recommended in patients with diabetes with suspected or known CAD, and those with autonomic neuropathy, retinopathy, or renal disease and scheduled to undergo intermediate- and high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 推荐对疑似或已知患有冠状动脉疾病的糖尿病患者，以及患有自主神经病变、视网膜病变或肾病并计划接受中高风险NCS的患者进行术前并发症评估。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
推荐对疑似或已知患有冠状动脉疾病的糖尿病患者，以及患有自主神经病变、视网膜病变或肾病并计划接受中高风险NCS的患者进行术前并发症评估。（证据级别：Level C ；推荐强度：Class Ⅰ）
A pre-operative assessment for concomitant cardiac conditions is recommended in patients with diabetes with suspected or known CAD, and those with autonomic neuropathy, retinopathy, or renal disease and scheduled to undergo intermediate- and high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 518
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/518.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => Stress imaging is recommended before high-risk elective NCS in patients with poor functional capacity and high likelihood of CAD or high clinical risk. (Evidence: Level B，Recommendation: Class Ⅰ)
[laiyuan] => 对于功能储备差、冠心病可能性大或临床高风险患者，推荐在高危择期NCS前进行运动显像检查。（证据级别：Level B ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于功能储备差、冠心病可能性大或临床高风险患者，推荐在高危择期NCS前进行运动显像检查。（证据级别：Level B ；推荐强度：Class Ⅰ）
Stress imaging is recommended before high-risk elective NCS in patients with poor functional capacity and high likelihood of CAD or high clinical risk. (Evidence: Level B，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 519
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/519.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In low-risk patients undergoing low- and intermediate-risk NCS, it is not recommended to routinely obtain pre-operative ECG, hs-cTn T/I, or BNP/NT-proBNP concentrations. (Evidence: Level B，Recommendation: Class Ⅲ)
[laiyuan] => 对于接受低危和中危NCS 的低危患者，不推荐常规术前心电图、高敏肌钙蛋白 T/I 或 BNP/NT-proBNP 浓度。（证据级别：Level B ；推荐强度：Class Ⅲ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于接受低危和中危NCS 的低危患者，不推荐常规术前心电图、高敏肌钙蛋白 T/I 或 BNP/NT-proBNP 浓度。（证据级别：Level B ；推荐强度：Class Ⅲ）
In low-risk patients undergoing low- and intermediate-risk NCS, it is not recommended to routinely obtain pre-operative ECG, hs-cTn T/I, or BNP/NT-proBNP concentrations. (Evidence: Level B，Recommendation: Class Ⅲ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
